Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...
The Operational and Finance Committee of the Board of Directors of Greenlam Industries Ltd has allotted 12,75,73,851 equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback